ATRA - ATARA BIOTHERAPEUTICS INC
This page shows which of the focused investors we track hold ATRA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2023 it was held by 3 managers with an aggregate reported value of $24.04M, which is 0.00% of the combined portfolio.
As of Q3 2023, 3 tracked institutional managers held ATRA (ATARA BIOTHERAPEUTICS INC) with an aggregate reported value of $24.04M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ATRA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2023
- Ticker
- ATRA
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Seth Klarman - Baupost Group | 0.28% | - | 9,773,616 | $14.47M |
| 2 | Lee Ainslie - Maverick Capital | 0.22% | - | 6,290,713 | $9.31M |
Call holders — bullish via leverage
1 manager holds call options on ATRA — a right to buy at strike. Notional value, not premium.
| 1 | Lee Ainslie - Maverick Capital | - | 181,100 | $268.03K |
Loading holder history for ATRA…